Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...
Illumina lowered its annual financial forecast and says it plans to cut about $100 million in costs after China banned imports of its gene sequencers last week. The San Diego maker of gene-sequencing ...
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.
Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...
Market OverviewGlobal Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of ...
A man was arrested Friday on suspicion of arson after officials responded to a brush fire in North County, officials said. The 20-year-old man is accused of setting the fire around 11:30 a.m ...
Re “San Diego’s infrastructure funding gap surges to $6.5 billion as growing needs outpace money” (Feb. 23): When big, unglamorous budget needs (infrastructure) are constantly kicked down ...
Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array-based solutions for genetic and genomic analysis. The one-month return of Illumina, Inc. (NASDAQ:ILMN) was -32.97%, and its shares lost 34 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results